Serial evoked potential studies and MRI imaging in chronic progressive multiple sclerosis

Journal of the Neurological Sciences

Volumn 171, Issue 2, 1999, Pages 79-83

  Sater, Richard A ^a   Rostami, A M ^a   Galetta, Steven ^a   Farber, Roger E ^a   Bird, Shawn J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brainstem auditory evoked potentials; Chronic progressive multiple sclerosis; MRI; Visual evoked potential

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DEMYELINATING DISEASE; DISABILITY; DISEASE COURSE; EVOKED BRAIN STEM RESPONSE; EVOKED RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL;

DISABILITY EVALUATION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE;

EID: 0032751477     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00255-5     Document Type: Article

References (30)

1. Matthews W.B., Wattam-Bell J.R., Pountney E. Evoked potentials in the diagnosis of multiple sclerosis: a follow-up study. J Neurol Neurosurg Psychiatry. 45:1982;303.
2. Beer S., Rosler K.M., Hess C.W. Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry. 59:1995;152.
3. Offenbacher H., Fazekas F., Schmidt R., Freidl W., Flooh E., Payer F., Lechner H. Assessment of MRI criteria for diagnosis of multiple sclerosis. Neurology. 43:1993;905.
4. Isaac C., Li D.K., Genton M., Jardine C., Grochowski E., Palmer M., Kastrukoff L.F., Oger J., Paty D.W. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology. 38:1988;1511.
5. Bottcher J., Trojaborg W. Follow-up of patients with suspected multiple sclerosis: a clinical and electrophysiological study. J Neurol Neurosurg Psychiatry. 45:1982;809.
6. Bednarik J., Kadanka Z. Multimodal sensory and motor evoked potentials in a two-year follow-up study of MS patients with relapsing course. Acta Neurol Scand. 86:1992;15.
7. Becker W.J., Richards I.M. Serial pattern shift visual evoked potentials in multiple sclerosis. Can J Neurol Sci. 11:1984;53.
8. Nuwer M.R., Packwood J.W., Myers L.W., Ellison G.W. Evoked potentials predict the clinical changes in a multiple sclerosis drug study. Neurology. 37:1987;1754.
9. Walsh J.C., Garrick R., Cameron J., McCleod J.G. Evoked potential changes in clinical definite multiple sclerosis: a two-year follow-up study. J Neurol Neurosurg Psychiatry. 45:1982;494.
10. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444.
11. Kjaer M. Variations of brainstem auditory evoked potentials correlated to duration and severity of multiple sclerosis. Acta Neurol Scand. 61:1980;157.
12. Davis S.L., Aminoff M.J., Panitch H.S. Clinical correlations of serial somatosensory evoked potentials in multiple sclerosis. Neurology. 35:1985;359.
13. Iragui V.J., Wiederholt W.C., Romine J.S. Serial recordings of multimodality evoked potentials in multiple sclerosis. Can J Neurol Sci. 13:1986;320.
14. Aminoff M.J., Davis S.L., Panitch H.S. Serial evoked potential studies in patients with definite multiple sclerosis: clinical relevance. Arch Neurol. 41:1984;1197.
15. Anderson D.C., Slater G.E., Sherman R., Ettinger M.G. Evoked potentials to test a treatment of chronic multiple sclerosis. Arch Neurol. 44:1987;1232.
16. Smith M.E., Stone L.A., Albert P.S., Frank J.A., Martin R., Armstrong M., Maloni H., McFarlin D.E., McFarland H.F. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol. 33:1993;480.
17. Uhlenbrock D., Seidel D., Gehlen W., Beyer H.K., Haan J., Dickmann E., Zeit T., Herbe E. MR imaging in multiple sclerosis: comparison with clinical, CSF and visual evoked potential findings. AJNR. 9:1988;59.
18. Rostami A.M., Sater R.A., Bird S.J., Galetta S., Farber R.E., Silberberg D.H., Grossman R.I., Pfohl D. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis. Mult Scler. 5:1995;198.
19. Sipe J.C., Knobler R.L., Braheny S.L., Rice G.P., Panitch H.S., Oldstone M.B. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology. 34:1984;1368.
20. Lehrich J.R., Beal M.F., Kevy S.V., Propper R.D., Mills J.A., Weiner H.L. Intensive immunosuppression in progressive multiple sclerosis: a randomized three-arm study of high dose intravenous cyclophosphamide, plasma exchange and ACTH. New Engl J Med. 308:1983;173.
21. Brorson J.R., Goldberg H.I., Silberberg D.H., Gonzalez-Scarano F. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology. 169:1988;117.
22. Goodkin D.E., Rudick R.A., Vanderbrug S., Daughtry M.M., Schwetz K.M., Fisher J., Van Dyke C. Low dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol. 37:1995;30.
23. Confavreux C., Mauguiere F., Courjon J., Aimard G., Devic M. Evolution des potentiels evoques visuels dans la sclerose en plaques. Rev Neurol (Paris). 137:1981;121.
24. Nuwer M.R., Packwood J.W., Ellison G.W., Myers L.W. A parametric scale for BAEP latencies in multiple sclerosis. Electroencephalogr Clin Neurophysiol. 71:1988;33.
25. Andersson T., Siden A., Persson A. A comparison of clinical and evoked potential (VEP and median nerve SEP) evolution in patients with MS and potentially related conditions. Acta Neurol Scand. 84:1991;139.
26. Emerson R.G. Evoked potentials in clinical trials for multiple sclerosis. J Clin Neurophysiol. 15:1998;109.
27. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology. 45:1995;1277.
28. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 43:1993;655.
29. Thompson A.J., Kermode A.G., Wicks D., MacManus D.G., Kendall B.E., Kingsley D.P., McDonald W.I. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol. 29:1991;53.
30. Tubridy N., Ader H.J., Barkhof F., Thompson A.J., Miller D.H. Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups. J Neurol Neurosurg Psychiatry. 64:1998;50.